SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001235010-19-000007
Filing Date
2019-08-07
Accepted
2019-08-07 17:11:06
Documents
76
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnta2q201910-q.htm   iXBRL 10-Q 2111522
2 EXHIBIT 10.1 mnta2q201910-qex101.htm EX-10.1 188155
3 EXHIBIT 31.1 mnta2q201910-qex311.htm EX-31.1 12385
4 EXHIBIT 31.2 mnta2q201910-qex312.htm EX-31.2 12487
5 EXHIBIT 32.1 mnta2q201910-qex321.htm EX-32.1 8584
  Complete submission text file 0001235010-19-000007.txt   8764859

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20190630.xsd EX-101.SCH 49608
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20190630_cal.xml EX-101.CAL 88475
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20190630_def.xml EX-101.DEF 212164
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnta-20190630_lab.xml EX-101.LAB 543058
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20190630_pre.xml EX-101.PRE 328041
11 EXTRACTED XBRL INSTANCE DOCUMENT mnta2q201910-q_htm.xml XML 1904547
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 191006392
SIC: 2836 Biological Products, (No Diagnostic Substances)